Literature DB >> 21779219

Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer.

Christoph Thomssen1, Nadia Harbeck.   

Abstract

Entities:  

Year:  2010        PMID： 21779219      PMCID： PMC3132961          DOI： 10.1159/000321137

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  48 in total

1.  Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy.

Authors:  R F Brem; V S Behrndt; L Sanow; O M Gatewood
Journal:  AJR Am J Roentgenol       Date:  1999-05       Impact factor: 3.959

2.  Prospective study of wide excision alone for ductal carcinoma in situ of the breast.

Authors:  Michael D Lagios; David L Page; Melvin J Silverstein
Journal:  J Clin Oncol       Date:  2006-08-10       Impact factor: 44.544

Review 3.  Post-operative radiotherapy for ductal carcinoma in situ of the breast--a systematic review of the randomised trials.

Authors:  Annabel Goodwin; Sharon Parker; Davina Ghersi; Nicholas Wilcken
Journal:  Breast       Date:  2009-05-17       Impact factor: 4.380

4.  LCIS found at core needle biopsy may not need surgical excision.

Authors:  Daniel B Kopans
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

5.  [Diagnosis of flat epithelial atypia (FEA) after stereotactic vacuum-assisted biopsy (VAB) of the breast: What is the best management: systematic surgery for all or follow-up?].

Authors:  N David; C Labbe-Devilliers; D Moreau; D Loussouarn; L Campion
Journal:  J Radiol       Date:  2006-11

6.  Lobular neoplasia on core needle biopsy does not require excision.

Authors:  Chandandeep S Nagi; James E O'Donnell; Mikhail Tismenetsky; Ira J Bleiweiss; Shabnam M Jaffer
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

7.  Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status.

Authors:  Richard J Bleicher; Robin M Ciocca; Brian L Egleston; Linda Sesa; Kathryn Evers; Elin R Sigurdson; Monica Morrow
Journal:  J Am Coll Surg       Date:  2009-06-18       Impact factor: 6.113

8.  Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer.

Authors:  Christopher I Li; Janet R Daling; Peggy L Porter; Mei-Tzu C Tang; Kathleen E Malone
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

9.  Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy.

Authors:  Robin M Ciocca; Tianyu Li; Gary M Freedman; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2008-05-28       Impact factor: 5.344

10.  Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.

Authors:  Stephen Chia; William Gradishar; Louis Mauriac; Jose Bines; Frederic Amant; Miriam Federico; Luis Fein; Gilles Romieu; Aman Buzdar; John F R Robertson; Adam Brufsky; Kurt Possinger; Pamela Rennie; Francisco Sapunar; Elizabeth Lowe; Martine Piccart
Journal:  J Clin Oncol       Date:  2008-03-03       Impact factor: 44.544
View more
  2 in total

1.  Radiotherapeutic Options for Symptom Control in Breast Cancer.

Authors:  Birgitt van Oorschot; Gabriele Beckmann; Wolfgang Schulze; Dirk Rades; Petra Feyer
Journal:  Breast Care (Basel)       Date:  2011-02-14       Impact factor: 2.860

Review 2.  Counselling framework for moderate-penetrance cancer-susceptibility mutations.

Authors:  Nadine Tung; Susan M Domchek; Zsofia Stadler; Katherine L Nathanson; Fergus Couch; Judy E Garber; Kenneth Offit; Mark E Robson
Journal:  Nat Rev Clin Oncol       Date:  2016-06-14       Impact factor: 66.675
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.